68
Participants
Start Date
February 22, 2017
Primary Completion Date
February 24, 2018
Study Completion Date
February 24, 2018
Dinoprostone
The DVI contains 10 mg dinoprostone
Yokota Maternity Hospital, Maebashi
Kitasato University Hospital, Sagamihara
Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi
Hamamatsu University Hospital, Hamamatsu
Seirei Hamamatsu General Hospital, Hamamatsu
Jichi Medical University Hospital, Shimotsuke
Itabashi Chuo Medical Center, tabashi City
University of Tsukuba Hospital, Ibaraki
Hori Hospital, Kanagawa
Rinku General Medical Center, Osaka
Juntendo University Hospital, Tokyo
Keio University Hospital, Tokyo
The University of Tokyo Hospital, Tokyo
Tokyo Metropolitan Bokutoh Hospital, Tokyo
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY